BACKGROUND AND PURPOSE: More than 85% of brain traumas are classified as "mild"; MR imaging findings are minimal if any and do not correspond to clinical symptoms. Our goal, therefore, was to quantify the global decline of the neuronal marker N-acetylaspartate (NAA), as well as gray (GM) and white matter (WM) atrophy after mild traumatic brain injury (mTBI). MATERIALS AND METHODS: Twenty patients (11 male, 9 female; age range, 19-57 years; median, 35 years) with mTBI (Glasgow Coma Scale score 13-15 with loss of consciousness for at least 30 seconds) and 19 age- and sex-matched control subjects were studied. Seven patients were studied within 9 days of TBI; the other 13 ranged from 1.2 months to 31.5 years (average and median of 4.6 and 1.7 years, respectively) after injury. Whole-brain NAA (WBNAA) concentration was obtained in all subjects with nonlocalizing proton MR spectroscopy. Brain volume and GM and WM fractions were segmented from T1-weighted MR imaging and normalized to the total intracranial volume, suitable for intersubject comparisons. The data were analyzed with least squares regression. RESULTS: Patients with mTBI exhibited, on average, a 12% WBNAA deficit that increased with age, compared with the control subjects (p<.05). Adjusted for age effects, patients also suffered both global atrophy (-1.09%/year; P=.029) and GM atrophy (-0.89%/year; P=.042). Patients with and without visible MR imaging pathology, typically punctate foci of suspected shearing injury, were indistinguishable in both atrophy and WBNAA. CONCLUSION: WBNAA detected neuronal/axonal injury beyond the minimal focal MR-visible lesions in mTBI. Combined with GM atrophy, the findings may provide further, noninvasive insight into the nature and progression of mTBI.
BACKGROUND AND PURPOSE: More than 85% of brain traumas are classified as "mild"; MR imaging findings are minimal if any and do not correspond to clinical symptoms. Our goal, therefore, was to quantify the global decline of the neuronal marker N-acetylaspartate (NAA), as well as gray (GM) and white matter (WM) atrophy after mild traumatic brain injury (mTBI). MATERIALS AND METHODS: Twenty patients (11 male, 9 female; age range, 19-57 years; median, 35 years) with mTBI (Glasgow Coma Scale score 13-15 with loss of consciousness for at least 30 seconds) and 19 age- and sex-matched control subjects were studied. Seven patients were studied within 9 days of TBI; the other 13 ranged from 1.2 months to 31.5 years (average and median of 4.6 and 1.7 years, respectively) after injury. Whole-brain NAA (WBNAA) concentration was obtained in all subjects with nonlocalizing proton MR spectroscopy. Brain volume and GM and WM fractions were segmented from T1-weighted MR imaging and normalized to the total intracranial volume, suitable for intersubject comparisons. The data were analyzed with least squares regression. RESULTS:Patients with mTBI exhibited, on average, a 12% WBNAA deficit that increased with age, compared with the control subjects (p<.05). Adjusted for age effects, patients also suffered both global atrophy (-1.09%/year; P=.029) and GM atrophy (-0.89%/year; P=.042). Patients with and without visible MR imaging pathology, typically punctate foci of suspected shearing injury, were indistinguishable in both atrophy and WBNAA. CONCLUSION: WBNAA detected neuronal/axonal injury beyond the minimal focal MR-visible lesions in mTBI. Combined with GM atrophy, the findings may provide further, noninvasive insight into the nature and progression of mTBI.
Authors: S De Santi; M J de Leon; H Rusinek; A Convit; C Y Tarshish; A Roche; W H Tsui; E Kandil; M Boppana; K Daisley; G J Wang; D Schlyer; J Fowler Journal: Neurobiol Aging Date: 2001 Jul-Aug Impact factor: 4.673
Authors: D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; D Ryser; S E Macnamara; B J Bailey Journal: AJNR Am J Neuroradiol Date: 1997-01 Impact factor: 3.825
Authors: B D Ross; T Ernst; R Kreis; L J Haseler; S Bayer; E Danielsen; S Blüml; T Shonk; J C Mandigo; W Caton; C Clark; S W Jensen; N L Lehman; E Arcinue; R Pudenz; C H Shelden Journal: J Magn Reson Imaging Date: 1998 Jul-Aug Impact factor: 4.813
Authors: Thierry A G M Huisman; Lee H Schwamm; Pamela W Schaefer; Walter J Koroshetz; Neetha Shetty-Alva; Yelda Ozsunar; Ona Wu; A Gregory Sorensen Journal: AJNR Am J Neuroradiol Date: 2004-03 Impact factor: 3.825
Authors: Elisabeth A Wilde; Sylvain Bouix; David F Tate; Alexander P Lin; Mary R Newsome; Brian A Taylor; James R Stone; James Montier; Samuel E Gandy; Brian Biekman; Martha E Shenton; Gerald York Journal: Brain Imaging Behav Date: 2015-09 Impact factor: 3.978
Authors: Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner Journal: J Rehabil Res Dev Date: 2009
Authors: Andrew A Maudsley; Varan Govind; Gaurav Saigal; Stuart G Gold; Leo Harris; Sulaiman Sheriff Journal: J Neuroimaging Date: 2017-07-23 Impact factor: 2.486
Authors: Kenny Lin; Michael J Taylor; Robert Heaton; Donald Franklin; Terry Jernigan; Christine Fennema-Notestine; Allen McCutchan; J Hampton Atkinson; Ronald J Ellis; Justin McArthur; Susan Morgello; David Simpson; Ann C Collier; Christina Marra; Benjamin Gelman; David Clifford; Igor Grant Journal: J Clin Exp Neuropsychol Date: 2011-01-10 Impact factor: 2.475
Authors: M E Shenton; H M Hamoda; J S Schneiderman; S Bouix; O Pasternak; Y Rathi; M-A Vu; M P Purohit; K Helmer; I Koerte; A P Lin; C-F Westin; R Kikinis; M Kubicki; R A Stern; R Zafonte Journal: Brain Imaging Behav Date: 2012-06 Impact factor: 3.978
Authors: Charles Gasparovic; Ronald Yeo; Maggie Mannell; Josef Ling; Robert Elgie; John Phillips; David Doezema; Andrew R Mayer Journal: J Neurotrauma Date: 2009-10 Impact factor: 5.269